BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freyberg Z, Aslanoglou D, Shah R, Ballon JS. Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia. Front Neurosci 2017;11:432. [PMID: 28804444 DOI: 10.3389/fnins.2017.00432] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Campeau A, Mills RH, Stevens T, Rossitto LA, Meehan M, Dorrestein P, Daly R, Nguyen TT, Gonzalez DJ, Jeste DV, Hook V. Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia. Mol Psychiatry 2021. [PMID: 34741130 DOI: 10.1038/s41380-021-01339-z] [Reference Citation Analysis]
2 Rostama B, Beauchemin M, Bouchard C, Bernier E, Vary CPH, May M, Houseknecht KL. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. Int J Mol Sci 2020;21:E9362. [PMID: 33302598 DOI: 10.3390/ijms21249362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 McWhinney S, Kolenic M, Franke K, Fialova M, Knytl P, Matejka M, Spaniel F, Hajek T. Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study. Schizophr Bull 2021:sbab064. [PMID: 34080013 DOI: 10.1093/schbul/sbab064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kowalchuk C, Kanagasundaram P, Belsham DD, Hahn MK. Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons. Psychoneuroendocrinology 2019;104:42-8. [PMID: 30802709 DOI: 10.1016/j.psyneuen.2019.01.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
5 Han M, Deng C. BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia. Neurosci Lett 2020;726:133870. [PMID: 30312750 DOI: 10.1016/j.neulet.2018.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Bucolo C, Leggio GM, Drago F, Salomone S. Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas. Pharmacol Ther 2019;203:107392. [PMID: 31299315 DOI: 10.1016/j.pharmthera.2019.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
7 Flintoff J, Kesby JP, Siskind D, Burne TH. Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential. Expert Opin Investig Drugs 2021;30:877-91. [PMID: 34213981 DOI: 10.1080/13543784.2021.1951702] [Reference Citation Analysis]
8 Soontornniyomkij V, Lee EE, Jin H, Martin AS, Daly RE, Liu J, Tu XM, Eyler LT, Jeste DV. Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms. Front Psychiatry 2019;10:251. [PMID: 31065243 DOI: 10.3389/fpsyt.2019.00251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Tasic L, Larcerda AL, Pontes JG, da Costa TBC, Nani JV, Martins LG, Santos LA, Nunes MF, Adelino MP, Pedrini M, Cordeiro Q, Bachion de Santana F, Poppi RJ, Brietzke E, Hayashi MAF. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder. Journal of Psychiatric Research 2019;119:67-75. [DOI: 10.1016/j.jpsychires.2019.09.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
10 Agarwal SM, Kowalchuk C, Castellani L, Costa-Dookhan KA, Caravaggio F, Asgariroozbehani R, Chintoh A, Graff-Guerrero A, Hahn M. Brain insulin action: Implications for the treatment of schizophrenia. Neuropharmacology 2020;168:107655. [PMID: 31152767 DOI: 10.1016/j.neuropharm.2019.05.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lee E, Jang MH. The Influence of Body Image, Insight, and Mental Health Confidence on Medication Adherence in Young Adult Women with Mental Disorders. Int J Environ Res Public Health 2021;18:3866. [PMID: 33917038 DOI: 10.3390/ijerph18083866] [Reference Citation Analysis]
12 Aslanoglou D, George EW, Freyberg Z. Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion. J Vis Exp 2018. [PMID: 29806846 DOI: 10.3791/57531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Galderisi S, De Hert M, Del Prato S, Fagiolini A, Gorwood P, Leucht S, Maggioni AP, Mucci A, Arango C. Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study. Eur Psychiatry 2021;64:e7. [PMID: 33413701 DOI: 10.1192/j.eurpsy.2020.115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Glausier JR, Enwright JF 3rd, Lewis DA. Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder. Am J Psychiatry 2020;177:1140-50. [PMID: 33115248 DOI: 10.1176/appi.ajp.2020.19111210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Fiorillo A, Sartorius N. Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal. Ann Gen Psychiatry 2021;20:52. [PMID: 34903254 DOI: 10.1186/s12991-021-00374-y] [Reference Citation Analysis]
16 Ogundele OM, Lee CC. CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4. Brain Res Bull 2018;137:53-70. [PMID: 29137928 DOI: 10.1016/j.brainresbull.2017.11.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
17 Paderina DZ, Boiko AS, Pozhidaev IV, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJM, Semke AV, Bokhan NA, Ivanova SA. Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia. J Pers Med 2021;11:181. [PMID: 33807811 DOI: 10.3390/jpm11030181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chang SC, Goh KK, Lu ML. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World J Psychiatr 2021; 11(10): 696-710 [PMID: 34733637 DOI: 10.5498/wjp.v11.i10.696] [Reference Citation Analysis]
19 Vassilopoulou E, Efthymiou D, Tsironis V, Athanassis P, Chatzioannidis S, Kesoglou T, Severin AV, Bozikas VP. The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics. Toxicology Reports 2022;9:120-5. [DOI: 10.1016/j.toxrep.2022.01.003] [Reference Citation Analysis]
20 Abd El-hameed AM, Eskandrani AA, Elroby FA. Assessment of the ameliorative effect of Hypericum perforatum on olanzapine-induced hepatic oxidative stress and metabolic abnormalities in experimental male albino rats. Journal of Taibah University for Science 2020;14:1496-502. [DOI: 10.1080/16583655.2020.1834757] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kucera J, Horska K, Hruska P, Kuruczova D, Micale V, Ruda-Kucerova J, Bienertova-Vasku J. Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue. Prog Neuropsychopharmacol Biol Psychiatry 2021;108:110165. [PMID: 33152383 DOI: 10.1016/j.pnpbp.2020.110165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chieh AY, Bryant BM, Kim JW, Li L. Systematic review investigating the relationship between autism spectrum disorder and metabolic dysfunction. Research in Autism Spectrum Disorders 2021;86:101821. [DOI: 10.1016/j.rasd.2021.101821] [Reference Citation Analysis]
23 Raue S, Wedekind D, Wiltfang J, Schmidt U. The Role of Proopiomelanocortin and α-Melanocyte-Stimulating Hormone in the Metabolic Syndrome in Psychiatric Disorders: A Narrative Mini-Review. Front Psychiatry 2019;10:834. [PMID: 31798479 DOI: 10.3389/fpsyt.2019.00834] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
24 Liu MZ, He HY, Luo JQ, He FZ, Chen ZR, Liu YP, Xiang DX, Zhou HH, Zhang W. Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives. Arch Pharm Res 2018;41:725-36. [PMID: 29858981 DOI: 10.1007/s12272-018-1039-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Farino ZJ, Morgenstern TJ, Maffei A, Quick M, De Solis AJ, Wiriyasermkul P, Freyberg RJ, Aslanoglou D, Sorisio D, Inbar BP, Free RB, Donthamsetti P, Mosharov EV, Kellendonk C, Schwartz GJ, Sibley DR, Schmauss C, Zeltser LM, Moore H, Harris PE, Javitch JA, Freyberg Z. New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion. Mol Psychiatry 2020;25:2070-85. [PMID: 30626912 DOI: 10.1038/s41380-018-0344-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
26 Aslanoglou D, Bertera S, Sánchez-Soto M, Benjamin Free R, Lee J, Zong W, Xue X, Shrestha S, Brissova M, Logan RW, Wollheim CB, Trucco M, Yechoor VK, Sibley DR, Bottino R, Freyberg Z. Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. Transl Psychiatry 2021;11:59. [PMID: 33589583 DOI: 10.1038/s41398-020-01171-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
27 Horska K, Kotolova H, Karpisek M, Babinska Z, Hammer T, Prochazka J, Stark T, Micale V, Ruda-Kucerova J. Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation. Toxicol Appl Pharmacol 2020;406:115214. [PMID: 32866524 DOI: 10.1016/j.taap.2020.115214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Han F, Konkalmatt P, Mokashi C, Kumar M, Zhang Y, Ko A, Farino ZJ, Asico LD, Xu G, Gildea J, Zheng X, Felder RA, Lee REC, Jose PA, Freyberg Z, Armando I. Dopamine D2 receptor modulates Wnt expression and control of cell proliferation. Sci Rep 2019;9:16861. [PMID: 31727925 DOI: 10.1038/s41598-019-52528-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Koricanac A, Borovcanin MM, Lucic AT. Еffects of Antipsychotics on Bone Mineral Density in Schizophrenia. Serbian Journal of Experimental and Clinical Research 2018;0:000010247820180036. [DOI: 10.2478/sjecr-2018-0036] [Reference Citation Analysis]
30 Wei H, Zapata RC, Lopez-Valencia M, Aslanoglou D, Farino ZJ, Benner V, Osborn O, Freyberg Z, McCarthy MJ. Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms. Psychoneuroendocrinology 2020;113:104551. [PMID: 31884319 DOI: 10.1016/j.psyneuen.2019.104551] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chipchura DA, Freyberg Z, Edwards C, Leckband SG, McCarthy MJ. Does the Time of Drug Administration Alter the Metabolic Risk of Aripiprazole? Front Psychiatry 2018;9:494. [PMID: 30364286 DOI: 10.3389/fpsyt.2018.00494] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]